These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23715620)

  • 1. Recovery from overt type 1 diabetes ensues when immune tolerance and β-cell formation are coupled with regeneration of endothelial cells in the pancreatic islets.
    Wan X; Guloglu FB; Vanmorlan AM; Rowland LM; Zaghouani S; Cascio JA; Dhakal M; Hoeman CM; Zaghouani H
    Diabetes; 2013 Aug; 62(8):2879-89. PubMed ID: 23715620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of pancreatic β-cells from precursor cells contributes to the reversal of established type 1 diabetes.
    Ukah TK; Cattin-Roy AN; Davis GE; Zaghouani H
    Cell Immunol; 2021 Jun; 364():104360. PubMed ID: 33866285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Type 1 Diabetes-Resistance Locus
    Whitener RL; Gallo Knight L; Li J; Knapp S; Zhang S; Annamalai M; Pliner VM; Fu D; Radichev I; Amatya C; Savinov A; Yurdagul A; Yuan S; Glawe J; Kevil CG; Chen J; Stimpson SE; Mathews CE
    J Immunol; 2017 Dec; 199(12):3991-4000. PubMed ID: 29109122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B lymphocytes protect islet β cells in diabetes prone NOD mice treated with imatinib.
    Wilson CS; Spaeth JM; Karp J; Stocks BT; Hoopes EM; Stein RW; Moore DJ
    JCI Insight; 2019 Apr; 5(9):. PubMed ID: 30964447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
    Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
    J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetes.
    Erdem N; Montero E; Roep BO
    Curr Opin Endocrinol Diabetes Obes; 2021 Aug; 28(4):397-403. PubMed ID: 34183540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
    Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
    J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance.
    Gregg RK; Bell JJ; Lee HH; Jain R; Schoenleber SJ; Divekar R; Zaghouani H
    J Immunol; 2005 Jan; 174(2):662-70. PubMed ID: 15634884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
    Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
    Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization.
    Bell GI; Broughton HC; Levac KD; Allan DA; Xenocostas A; Hess DA
    Stem Cells Dev; 2012 Jan; 21(1):97-109. PubMed ID: 21417581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes.
    Moore DJ; Zienkiewicz J; Kendall PL; Liu D; Liu X; Veach RA; Collins RD; Hawiger J
    PLoS One; 2010 Oct; 5(10):e13235. PubMed ID: 20949090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Old Dog New Tricks: PLGA Microparticles as an Adjuvant for Insulin Peptide Fragment-Induced Immune Tolerance against Type 1 Diabetes.
    Liu M; Feng D; Liang X; Li M; Yang J; Wang H; Pang L; Zhou Z; Yang Z; Kong D; Li C
    Mol Pharm; 2020 Sep; 17(9):3513-3525. PubMed ID: 32787283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet-immune interactions in type 1 diabetes: the nexus of beta cell destruction.
    Peters L; Posgai A; Brusko TM
    Clin Exp Immunol; 2019 Dec; 198(3):326-340. PubMed ID: 31309537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectratyping analysis of the islet-reactive T cell repertoire in diabetic NOD Igμ(null) mice after polyclonal B cell reconstitution.
    Vong AM; Daneshjou N; Norori PY; Sheng H; Braciak TA; Sercarz EE; Gabaglia CR
    J Transl Med; 2011 Jul; 9():101. PubMed ID: 21722394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.
    Silveira PA; Grey ST
    Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific therapy against type 1 diabetes: mechanisms and perspectives.
    Wan X; Zaghouani H
    Immunotherapy; 2014; 6(2):155-64. PubMed ID: 24491089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.